A whole population study of gastrointestinal stromal tumors in the Czech Republic and Slovakia

Neoplasma

Volumn 56, Issue 5, 2009, Pages 459-464

  Brabec, P ^a   Sufliarsky, J ^b   Linke, Z ^c   Plank, L ^d   Mrhalova, M ^c   Pavlik, T ^a   Klimes, D ^a   Gregor, J ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b National Oncology Institute   (Slovakia)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d MARTIN FACULTY HOSPITAL   (Slovakia)

Author keywords

Epidemiology; Gastrointestinal stromal tumor; Incidence; Registry; Risk category; Survival

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; MITOSIS RATE; OVERALL SURVIVAL; SLOVAKIA; TUMOR VOLUME; FEMALE; MALE; MIDDLE AGED; MITOSIS; MORTALITY; PATHOLOGY; REGISTER;

FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; MITOSIS; REGISTRIES; SLOVAKIA;

EID: 69849105576     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_05_459     Document Type: Article

References (12)

1. Mucciarini C, Rossi G, Bertolini F et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007; 7: 230. doi:10.1186/1471-2407-7-230 PMid:18096058 PMCid:2241631
2. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004; 22: 3813-3825. doi:10.1200/JCO.2004.05.140 PMid:15365079
3. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478. (Pubitemid 44520713)
4. Nilsson B, Bumming P, Meis-Kindblom JM et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era. A population-based study in western Sweden. Cancer 2005; 103: 821-829.
5. Kindblom LG, Remotti HE, Aldenborg F et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152: 1259-1269. (Pubitemid 28221878)
6. Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580. doi:10.1126/science.279.5350.577 PMid:9438854 (Pubitemid 28067289)
7. Heinrich MC, Blanke CD, Druker BJ et al. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002; 20: 1692-1703. doi:10.1200/JCO.20.6.1692 PMid:11896121
8. Goettsch WG, Bos SD, Breekveldt-Postma N et al. Incidence of gastrointestinal stromal tumors is underestimated: Results of a nation-wide study. Eur J Cancer 2005; 41: 2868-2872. doi:10.1016/j.ejca.2005.09.009 PMid:16293410 (Pubitemid 41713125)
9. Rubió J, Marcos-Gragera R, Ortiz MR et al. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. Eur J Cancer 2007; 43: 144-148. doi:10.1016/j.ejca.2006.07.015 PMid:17055254 (Pubitemid 46054472)
10. Tryggvason G, Kristmundsson P, Orvar K et al. Clinical study on gastrointestinal stromal tumors (GIST) in Iceland, 1990-2003. Dig Dis Sci 2007; 52: 2249-2253. doi:10.1007/s10620-006-9248-4 PMid:17420941
11. Fletcher CDM, Berman JJ, Corless C et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002; 33: 459-465. doi:10.1053/hupa.2002.123545 PMid:12094370 (Pubitemid 34747864)
12. Blay JY, Bonvalot S, Casali P et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 2005; 16: 566-578 doi:10.1093/annonc/mdi127 PMid:15781488